Top 10 healthcare companies in the U.S. based on revenue
The past couple years have been exceptionally busy ones in the healthcare industry, as companies have been adapting to regulations of the Affordable Care Act (ACA) as well as seeking new merger and acquisition targets in the pharmaceutical and biotech sectors.
All 10 of the companies in this list are in Fortune’s top 50, which reveal the dominance of healthcare in the U.S. economy.
Below is the list of the top 10 largest healthcare companies in the U.S. based on revenue:
10. Aetna ($58 billion)
The Hartford, Conn.-based health insurance company took an unexpected rise early this year when it increased its minimum wage to $16 an hour. Although the industry has been affected in both good and bad ways by the ACA, Aetna has seen an increase in employees and worker production.
9. Anthem ($73.9 billion)
Previously known as Wellpoint, Anthem is still overcoming a data security breach in February, as the Indianapolis-based company had its database hacked. However, the second-largest health insurer in the U.S. has a growing member base along with a falling price for customers.
8. Johnson & Johnson ($74.3 billion)
With a total of 24 brands that bring in over $1 billion in sales, most of this is attributed to the company’s pharmaceutical division, which is one of the fastest growing in the U.S., Europe and Japan.
7. Walgreens Boots Alliance ($76.4 billion)
With stores in over 25 countries, this is the largest retail pharmacy company in the U.S. and Europe. The merger between Walgreens and UK-based Alliance Boots made it the first global, pharmacy-led health and wellbeing enterprise in the world.
6. Cardinal Health ($91.1 billion)
The drug wholesaler purchased Johnson & Johnson’s Cordis heart-product business for $1.94 billion back in March, allowing Cardinal to add even more products to its inventory.
5. Express Scripts Holdings ($100.9 billion)
A full-service manager of pharmacy benefits, Express Scripts helped lead the sector’s new trend of consolidation after purchasing Medco Health Solutions in 2012. That deal has since doubled the company’s revenues and made it the top pharmacy benefits manager.
RELATED TOPIC: The rise of pharma sales and the impact on patient care
4. AmerisourceBergen ($119.6 billion)
One of the world’s largest global pharmaceutical distribution and sourcing services companies, AmerisourceBergen’s partnership with Walgreens Boots Alliance provided a hefty boost in revenue with even more gains expected in the future.
3. UnitedHealth Group ($130.5 billion)
Serving over 85 million patients across the globe with health benefits and services, the largest health insurer in the U.S. has also invested heavily in its health services arm Optum, which includes health data analytics as well as a pharmacy benefits manager (PBM).
RELATED TOPIC: Health care M&A activity continues to soar in 2015
2. McKesson ($138 billion)
The largest pharmaceutical distributor in the U.S., McKesson has been on the rise behind its increased sales in wholesale drug distribution segment, as well as taking a larger stake in Celesio. The San Francisco-based company finally acquired Celesio in full at the beginning of 2014, and now focuses on developing, implementing and supporting software within the medical community.
1.CVS Health ($139.4 billion)
After already owning the top spot as the nation’s leading prescription drug retailer and the second-largest pharmacy benefits manager, CVS Health is expanding in an attempt to become a fully-integrated provider of health services. This year, the company purchased Target’s 1,600 pharmacies as well as drug delivery company Omnicare. Following these deals, CVS Health has been in the process of transitioning into a full-service health management company.
Click here to read the latest edition of Healthcare Global magazine!
Top 10 healthcare innovations for 2019
We take a look at some of the top 10 healthcare innovations which are transforming the sector
The telehealth market is booming. Consumers are leading increasingly busy lifestyles, with up to 60% favouring digitally-led services. Providing clinical care at a distance, increasing accessibility and eradicating potential delays has given patients greater control, boosting patient satisfaction and overall engagement. Such is its exponential growth, The Centers for Medicare and Medicaid Services in the US has recently released its proposed Physician Fee Schedule and Qualified Payment Programme updates for 2019, where telehealth services has been heavily featured, in order to deliver ‘different access points’ for patients.
9. Mobile technology
Consumers have become accustomed to accessing their data through the use of various digital tools, where the use of mobile and tablet health apps has tripled from 13% in 2014 to 48% today. Catering to this growing market, British based start-up Babylon Health is making waves on a global scale. Partnering with the National Health Service (NHS) and private health provider, Bupa, it has also cemented its presence across the flourishing Chinese market, with a membership base exceeding 1.4mn citizens across Europe, Asia and Africa. By partnering with global juggernaut Tencent, Babylon’s artificial intelligence system has enabled both parties to interact directly with users, identify specific illnesses, deliver health status assessments, and triage necessary actions. The mobile app is available to over a billion users and linked to more than 38,000 medical facilities in China alone.
8. Artificial intelligence
Artificial intelligence (AI) applications, such as predictive analytics for patient monitoring has provided significant financial savings. Applications that target hospitals and medical institutions include patient monitoring and transcribing notes for electronic health records (EHRs). The European Union is set to invest $24bn into artificial intelligence (AI) by 2020 in a bid to catch up with Asia and the US, who have invested heavily in AI and cloud services. This year, Google revealed its plans to harness AI and machine learning across a multitude of consumer technologies, particularly in healthcare. “If AI can shape healthcare, it has to work through the regulations of healthcare. In fact, I see that as one of the biggest areas where the benefits will play out for the next 10-20 years,” Google CEO Sundar Pichai has previously stated.
Blockchain is estimated to reach over $5.61bn by the end of 2025, even though it remains dependent on the ability to record and store information conveniently, economically and securely amongst different applications and systems. Providing transparency and eliminating third-party intermediaries, processes are streamlined, reducing healthcare costs exponentially. Unlocking the ability for providers to deliver a value-based healthcare system and enhance patient engagement, blockchain could save the industry up to $100-$150bn per year by 2025 in data breach-related costs, IT costs, operations costs, support function costs and personnel costs, according to BIS Research. Partnering with pharmaceutical giant GlaxoSmithKline (GSK), Ethereum blockchain-based supply chain platform, Viant sought to accelerate the pace of blockchain-based supply chain systems. Accenture and supply chain giant DHL have also developed a blockchain-based serialisation prototype which tracks pharmaceuticals from the point of origin to the consumer.
6. Health wearables
With the rise of lifestyle diseases, such as diabetes, more consumers are turning to health wearables that monitor glucose, heart rate, physical activity and sleep to gain a greater understanding of their health conditions. Following on from the release of the first Bluetooth headset back in 2000, the growing interest in wearables has seen monitoring our health and data become standardised. This data can be analysed by sophisticated algorithms to drive long-term diagnosis and support. Partnering with Google, health wearables company Fitbit is exploring the development of consumer and enterprise health solutions. Its acquisition of HIPAA-compliant health platform, Twine Health has seen the business enhance its clinical services by bringing on board a coaching platform, empowering people to seek better health outcomes.
- Novartis Social Business: Blending profit with purpose
- How Microsoft is transforming Canada's healthcare
- The December edition of Healthcare Global is live!
5. Electronic health records tools
From 2018-2022, the electronic health records (EHR) market is expected to grow at a compound average rate of 6% per year Providers and organisations continue to house fragmented technologies which create barriers towards collaboration and data sharing opportunities. This is further exacerbated if a patient straddles both public and private healthcare. Technology giant Apple has integrated patients’ medical records into its Health App as part of its iOS 11.3 beta. The data is encrypted and protected with the user’s iPhone passcode. Partnering with hospital providers and clinics, patients are now able to view their medical records from multiple providers within one platform. Johns Hopkins Medicine, Cedars-Sinai, Penn Medicine, UC San Diego Health and even the Cleveland Clinic have implemented this technology.
4. Healthcare transportation
Non-emergency health transportation remains a key issue worldwide, preventing patients from getting to or from a doctor’s appointment. 25% of lower-income patients have missed or rescheduled appointments due to lack of transportation, costing US health systems up to $150bn each year. Transportation companies such as Lyft and Uber have therefore entered the market by partnering with state governments to reduce these costs and deliver personalised patient care.
3. 3D Printing
Healthcare providers are set to represent the second largest industry sector in 3D manufacturing. The Food & Drug Administration’s decision to release its first comprehensive framework advising manufacturers of 3D medical products highlights its growing impact where more than 100,000 knee replacement surgeries are completed each year using 3D-printed, patient-matched surgical guides, for example. Through this process, surfaces and structures can be optimised for strength, weight and material use. Consultation between surgeons and patients has also been bolstered, where patients can better understand the complexity of his or her specific needs.
As consumers get more involved in the management of their health, consumer genetics and research companies have grown in popularity and scale. People want to further understand their genetic makeup, leading personal genomics and biotech company 23andMe to become one of the largest consumer-based organisations worldwide. Interestingly, this year, the company has entered a four-year collaboration with GSK to develop new treatments, but using human genetics as the basis for discovery.
Not only looking to develop treatments by analysing human genetics, pharmaceutical companies are looking to even remove hereditary genes which pass diseases down generations. In 2017, human embryos were successfully ‘edited’ through gene editing tool, CRISPR (Clustered, Regularly Interspaced, Short Palindromic Repeats), eradicating hypertrophic cardiomyopathy within 42 embryos.
1. Vertical integrations
As healthcare providers aim to provide greater transparency, promote collaboration and lower escalating patient costs, 2018 has been the year for a significant number of vertical integrations. CVS Health’s $68mn takeover of health insurer Aetna is a case in point. By influencing more of the supply chain, it will gain significant negotiating power to reduce costs for payers and patients, develop personalised solutions and improve overall outcomes. It will also promote the eradication of delays in process by removing any third parties within traditional business models. Other notable integrations are Optum’s acquisition of the DaVita Medical Group, Humana and Kindred Healthcare and Cigna and Express Scripts.
Reports have indicated that not only has the number of healthcare deals more than doubled in the last five years, the size of deals has also grown as a result of repeat investor interest, highlighting that this trend is here to stay.